Healthcare & Life Sciences
Encoded Therapeutics
United Statesencodedtx.com
Encoded Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Encoded Therapeutics
Encoded Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Encoded Therapeutics develops precision gene therapies designed to address the root cause of severe neurological disorders, with a focus on Dravet syndrome through its lead program ETX101.
Explore Encoded Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.